This activity is expired and is no longer available for CME credit.


Rho Kinase Inhibitors for Glaucoma Treatment

Author(s)/Faculty: Richard A. Lewis, MD
Release Date: 9/19/2016Expiration Date: 9/18/2017
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
Rho kinase (ROCK) inhibitors are a novel potential class of glaucoma therapeutics, relaxing the trabecular meshwork through inhibition of the actin cytoskeleton contractile tone of smooth muscle.  This video will review their potential role in glaucoma treatment.